What Botox Actually Does

Botulinum toxin type A is a purified protein that temporarily blocks the chemical signal travelling from a nerve ending to a muscle fibre. The muscle does not receive its instruction to contract, so it relaxes. The effect is local, it is dose-dependent, and it is temporary: the nerve gradually grows new terminals, the signal is restored, and movement returns.

That mechanism explains the single most important distinction in the whole subject. Toxin works on dynamic lines — the creases that appear when you frown, squint, or raise your brows. It has very little to offer for static lines, the ones already etched into the skin at rest, because those are a structural change in the dermis rather than a muscle pulling.

What has come to be described as the Korean approach is less a different drug than a different dosing philosophy. Rather than a few larger deposits, practitioners tend to distribute smaller units across a greater number of injection points, aiming to reduce the pull of a muscle without abolishing it. The intent is a face that still moves, photographs normally, and simply creases less.

The Areas Korean Clinics Treat Most

The upper face is common everywhere. What is more particular to Korean practice is how routinely toxin is used below the eyes and off the face entirely, for contour rather than for wrinkles.

• Glabella and forehead — the frown complex between the brows and the horizontal lines above it. Conservative dosing here matters more than anywhere else, because the forehead muscle is also what holds the brow up.
• Crow's feet — the fan of lines at the outer eye. Usually treated with very small units placed superficially.
• Bunny lines — the diagonal creases across the bridge of the nose that often become more visible after the glabella has been treated.
• Masseter — the chewing muscle at the angle of the jaw. Reducing its bulk narrows the lower face and can also ease the clenching and grinding that thickened it in the first place.
• Mentalis — the chin muscle, treated when it produces a dimpled or pebbled texture on movement.
• Platysma — the vertical neck bands, sometimes combined with jawline points in what is often called a Nefertiti lift.
• Trapezius — the muscle running from neck to shoulder. Softening it lengthens the visible neck line and, for some patients, eases the tension and stiffness that accompany a habitually raised shoulder.

The last of those is worth flagging for anyone arriving from abroad. Trapezius injection for shoulder line was popularised in Korea long before it circulated internationally under names such as TrapTox or barbie botox, and it remains one of the requests Seoul clinics see most often from overseas patients.

Korea's Domestic Toxin Brands

Patients who research treatment in Korea quickly encounter brand names that are unfamiliar elsewhere. Korea has an unusually crowded domestic market for botulinum toxin type A, and several of its manufacturers now export. Botulax is produced by Hugel; Nabota by Daewoong, and is distributed in the United States under a different trade name; Meditoxin, Innotox and Coretox come from Medytox; Neuronox is another long-standing domestic product. Non-Korean products such as Botox, Dysport and Xeomin are also widely available in Seoul clinics.

They differ in ways that are more technical than promotional. Some are supplied freeze-dried, some vacuum-dried, and at least one is sold as a ready-mixed liquid that removes the reconstitution step. Unit strength is not interchangeable between products, which is the practical reason a dose quoted for one brand cannot simply be carried across to another.

None of this makes one product superior to another. Which toxin is appropriate depends on the muscle being treated, the dose required, your own treatment history, and the practitioner's familiarity with a given product. A clinic should be able to tell you which product it is using and why — and that answer, rather than the brand name itself, is the useful information.

A Session, and Why Timelines Differ by Area

The appointment itself is short. After a consultation in which the practitioner watches you frown, smile and clench, the injection points are marked and treated with a fine needle. Most patients describe a brief sting rather than pain, and topical numbing is offered but frequently declined. Aftercare is minimal: avoid rubbing or massaging the area, stay upright for a few hours, and skip strenuous exercise, saunas and jjimjilbang for the rest of the day. Small bruises are possible at any injection site and settle on their own.

What surprises many first-time patients is that the timeline is not the same everywhere on the body. For expression lines, softening usually begins within several days and the result settles at around two weeks. For the masseter and the trapezius, the mechanism is different — you are waiting for a bulky muscle to lose volume through disuse, not simply for a crease to relax. That change unfolds over weeks to a couple of months, and the visible contour arrives long after the injection is forgotten.

Duration follows the same logic. Facial results are commonly quoted in the range of three to four months, while masseter and trapezius results often persist longer because the muscle itself has to rebuild. Individual metabolism, dose and how hard you use the muscle all shift these figures, so treat them as a range rather than a promise.

What Botox Cannot Do

A great deal of disappointment comes from asking toxin to solve a problem that is not muscular. It is worth being specific about the boundaries.

It does not fill. Hollow temples, flattened cheeks and deep nasolabial folds are volume problems. Relaxing a muscle does not replace lost fat or bone support, and toxin used in an attempt to do so tends to produce a heavier, flatter result rather than a fuller one.

It does not lift sagging skin. Laxity along the jawline or in the lower face reflects changes in skin and supporting tissue. That territory belongs to energy-based devices, thread lifting or surgery, and a consultation that reaches for toxin alone is not addressing what you came in about.

It does not erase a line already etched at rest. Once a crease is visible on a completely relaxed face, the fold is in the skin itself. Toxin may stop it deepening; resurfacing, microneedling or filler are what address the existing groove.

It does not change bone. This one matters most for the jaw. A wide lower face caused by an enlarged masseter will narrow; a wide lower face caused by the mandible itself will not. The distinction is made at examination, not by guessing from a photograph.

It is not permanent, and it does not suit everyone. Results fade and maintenance is part of the decision. Treatment is generally avoided in pregnancy and breastfeeding, in neuromuscular conditions such as myasthenia gravis, and where there is infection at the intended injection site. Frequent high-dose treatment at short intervals also carries a possibility of reduced response over time, which is one reason unnecessary top-ups are discouraged. Any medication, supplement or prior toxin treatment should be disclosed before injection.